Glioblastoma (GBM) is an aggressive and challenging primary brain tumor with poor prognosis despite advances in surgical resection, radiotherapy, and chemotherapy. Recently, targeting tumor cell metabolic pathways has emerged as a promising strategy for cancer treatment. 6-Phosphofructo-2-kinase/…